Piloting the Global Subsidy: The Impact of Subsidized Artemisinin-Based Combination Therapies Distributed through Private Drug Shops in Rural Tanzania

BACKGROUND: WHO estimates that only 3% of fever patients use recommended artemisinin-based combination therapies (ACTs), partly reflecting their high prices in the retail sector from where many patients seek treatment. To overcome this challenge, a global ACT subsidy has been proposed. We tested thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabot, Oliver J., Mwita, Alex, Cohen, Justin M., Ipuge, Yahya, Gordon, Megumi, Bishop, David, Odhiambo, Moses, Ward, Lorrayne, Goodman, Catherine
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2730578/
https://www.ncbi.nlm.nih.gov/pubmed/19724644
http://dx.doi.org/10.1371/journal.pone.0006857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2730578/
https://www.ncbi.nlm.nih.gov/pubmed/19724644
http://dx.doi.org/10.1371/journal.pone.0006857

Ejemplares similares